| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |